Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our Plans

Compare everything

See all plans, pricing and what each product includes side by side.

Plans & Subscriptions

Explore

Analyst Notes

Stocks – Q : Quality | V : Valuation | PT : Price Trend
Funds – P : Performance | Q : Quality

Top Pharma Companies in India by Market Cap

BSE Sensex 76923.00
87.22 (0.11%)

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Jubilant Pharmova Ltd.	Q V+ PT	15,582 Small Cap	960 (-1.87%)	783	6.74	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Jupiter Life Line Hospitals Ltd.	Q V PT	10,728 Small Cap	322.10 (-1.57%)	56.06	6.67	21.03	54.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,127 Small Cap	130.45 (0.00%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Kopran Ltd.	Q V PT	975 Small Cap	198.50 (-1.68%)	32.07	2.18	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Kovai Medical Center & Hospital Ltd.	Q V PT	6,411 Small Cap	5,946.75 (1.51%)	26.22	4.86	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Krishna Institute of Medical Sciences Ltd	Q V PT	33,598 Small Cap	791.35 (-1.08%)	128.88	8.55	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Krsnaa Diagnostics Ltd.	Q V+ PT	1,758 Small Cap	536.65 (-0.98%)	17.33	1.79	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,815 Small Cap	2,650.95 (-2.29%)	41.8	8.47	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Laurus Labs Ltd.	Q V+ PT	92,623 Mid Cap	1,745.85 (1.84%)	84.7	16.43	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Laxmi Dental Ltd.	Q V PT	1,198 Small Cap	217.15 (-0.41%)	72.96	4.85	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Lincoln Pharmaceuticals Ltd.	Q V PT	1,163 Small Cap	581.95 (0.25%)	13.23	1.53	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Lupin Ltd.	Q V PT	1,10,189 Mid Cap	2,405.20 (-0.20%)	20.66	4.92	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Mankind Pharma Ltd.	Q V PT	1,05,357 Mid Cap	2,586.60 (1.39%)	51.71	6.44	13.54	13.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Marksans Pharma Ltd.	Q V+ PT	11,941 Small Cap	258.90 (-1.75%)	39.71	7.23	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Max Healthcare Institute Ltd.	Q V PT	1,08,476 Mid Cap	1,112.35 (-0.20%)	75.2	10.23	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Metropolis Healthcare Ltd.	Q V PT	11,981 Small Cap	590.30 (2.17%)	63.05	7.92	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Morepen Laboratories Ltd.	Q V PT	3,101 Small Cap	55.65 (-1.66%)	46.94	2.5	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Narayana Hrudayalaya Ltd.	Q V PT	41,974 Mid Cap	2,070.10 (0.79%)	52.1	9.25	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Natco Pharma Ltd.	Q V PT	16,606 Small Cap	925.15 (-0.22%)	11.71	1.8	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Nectar Lifesciences Ltd.	Q V PT	202 Small Cap	10.42 (0.00%)	N/A	0.35	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Nephrocare Health Services Ltd.	Q V+ PT	6,853 Small Cap	689.80 (1.22%)	N/A	7.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Neuland Laboratories Ltd.	Q V+ PT	24,345 Small Cap	18,887 (-0.47%)	67.05	13.05	16.64	37.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Novartis India Ltd.	Q V+ PT	4,023 Small Cap	1,614.10 (-0.92%)	41.14	4.73	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Onesource Specialty Pharma Ltd.	Q V PT	19,375 Small Cap	1,744.75 (3.26%)	406.87	3.23	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Orchid Pharma Ltd.	Q V PT	5,002 Small Cap	986.40 (0.01%)	110.65	3.65	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Panacea Biotec Ltd.	Q V+ PT	2,654 Small Cap	418.10 (-3.51%)	N/A	9.3	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Park Medi World Ltd.	Q V+ PT	12,060 Small Cap	279.20 (0.00%)	329.35	14.02	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Pfizer Ltd.	Q V PT	21,456 Small Cap	4,706.75 (0.35%)	29.7	5.11	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Piramal Pharma Ltd.	Q V PT	25,569 Small Cap	188.40 (-1.90%)	36.53	3.17	10.23	-6.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Poly Medicure Ltd.	Q V PT	17,025 Small Cap	1,670.15 (-0.57%)	50.67	5.58	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Company Name	CMP	Price Change(%)
Onesource Specialty	1,744.75	3.26%
Dr. Agarwals Health	487.60	2.53%
Metropolis Health.	590.30	2.17%
Laurus Labs	1,745.85	1.84%
Cipla	1,434.80	1.77%

Company Name	CMP	Price Change(%)
Acutaas Chemicals	3,121.05	-7.35%
Senores Pharmaceutic	1,317.55	-6.66%
Suven Life Sciences	297.85	-4.44%
Wanbury	318.55	-3.82%
Panacea Biotec	418.10	-3.51%

News about Top Pharma Companies in India

Jul, 2026

Laurus Labs - Quaterly Results

The company witnessed a 22.64% growth in the revenue at Rs. 17571.60 millions for the quarter ended June 2026 as compared to Rs. 14327.50 millions during the year-ago period.Profit for the quarter ended June 2026 rises by 83.59% to Rs. 2899.60 millions from Rs. 1579.40 millions.Operating profit for the quarter ended June 2026 rose to 5191.30 millions as compared to 3489.00 millions of corresponding quarter ended June 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	17571.60	14327.50	22.64	17571.60	14327.50	22.64	60890.70	52169.80	16.72
Other Income	200.70	215.20	-6.74	200.70	215.20	-6.74	774.30	1004.70	-22.93
PBIDT	5191.30	3489.00	48.79	5191.30	3489.00	48.79	15156.90	10448.00	45.07
Interest	352.00	438.90	-19.80	352.00	438.90	-19.80	1429.60	1822.00	-21.54
PBDT	4839.30	3050.10	58.66	4839.30	3050.10	58.66	13727.30	8626.00	59.14
Depreciation	957.60	935.70	2.34	957.60	935.70	2.34	3786.40	3587.90	5.53
PBT	3881.70	2114.40	83.58	3881.70	2114.40	83.58	9940.90	5038.10	97.31
TAX	982.10	535.00	83.57	982.10	535.00	83.57	2536.10	1234.20	105.49
Deferred Tax	-50.40	-61.60	-18.18	-50.40	-61.60	-18.18	-315.10	-304.20	3.58
PAT	2899.60	1579.40	83.59	2899.60	1579.40	83.59	7404.80	3803.90	94.66
Equity	1080.50	1079.60	0.08	1080.50	1079.60	0.08	1079.70	1078.50	0.11
PBIDTM(%)	29.54	24.35	21.32	29.54	24.35	21.32	24.89	20.03	24.29

Jul, 2026

Onesource Specialty - Quaterly Results

A decent increase of about 39.08% in the sales to Rs. 4464.71 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 3210.12 millions during the year-ago period.The company almost doubled its revenue to Rs. 512.25 millions from Rs. 248.15 millions in the quarter ended June 2026.Operating Profit saw a handsome growth to 1179.19 millions from 851.30 millions in the quarter ended June 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	4464.71	3210.12	39.08	4464.71	3210.12	39.08	14053.81	12995.89	8.14
Other Income	37.87	52.55	-27.94	37.87	52.55	-27.94	150.08	176.82	-15.12
PBIDT	1179.19	851.30	38.52	1179.19	851.30	38.52	2840.01	3869.57	-26.61
Interest	305.17	270.31	12.90	305.17	270.31	12.90	1205.76	1616.50	-25.41
PBDT	874.02	580.99	50.44	874.02	580.99	50.44	1580.05	1130.57	39.76
Depreciation	361.77	332.84	8.69	361.77	332.84	8.69	1367.95	1345.12	1.70
PBT	512.25	248.15	106.43	512.25	248.15	106.43	212.10	-214.55	-198.86
TAX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-414.55	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-414.55	0.00
PAT	512.25	248.15	106.43	512.25	248.15	106.43	212.10	200.00	6.05
Equity	114.64	114.46	0.16	114.64	114.46	0.16	114.62	114.43	0.17
PBIDTM(%)	26.41	26.52	-0.41	26.41	26.52	-0.41	20.21	29.78	-32.13

Jul, 2026

Panacea Biotec informs about disclosure

Pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), Panacea Biotec has informed that the Company’s wholly owned subsidiary, Panacea Biotec Pharma (‘PBPL’), has received a Show Cause Notice dated July 23, 2026, from the office of the Assistant Commissioner, Goods and Services Tax (‘GST’), Delhi under Section 73 of Delhi Goods & Services Tax / Central Goods & Services Tax Act & Rules, 2017 alleging total tax liability of ?4.06 Crore including interest, tax and penalty, on account of alleged excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23. The requisite details as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations, are annexed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Novartis India - Quaterly Results

The June 2026 quarter revenue stood at Rs. 1038.10 millions, up 18.57% as compared to Rs. 875.50 millions during the corresponding quarter last year.A humble growth in net profit of 16.62% reported in the quarter ended June 2026 to Rs. 322.10 millions from Rs. 276.20 millions.The company reported a good operating profit of 436.50 millions compared to 378.50 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	1038.10	875.50	18.57	1038.10	875.50	18.57	3543.30	3562.70	-0.54
Other Income	87.40	106.10	-17.62	87.40	106.10	-17.62	387.70	419.60	-7.60
PBIDT	436.50	378.50	15.32	436.50	378.50	15.32	1328.70	1333.80	-0.38
Interest	0.60	1.00	-40.00	0.60	1.00	-40.00	12.60	7.70	63.64
PBDT	435.90	377.50	15.47	435.90	377.50	15.47	1316.10	1326.10	-0.75
Depreciation	4.20	5.30	-20.75	4.20	5.30	-20.75	19.50	21.90	-10.96
PBT	431.70	372.20	15.99	431.70	372.20	15.99	1296.60	1304.20	-0.58
TAX	109.60	96.00	14.17	109.60	96.00	14.17	364.80	295.20	23.58
Deferred Tax	-5.00	0.00	0.00	-5.00	0.00	0.00	15.30	-4.40	-447.73
PAT	322.10	276.20	16.62	322.10	276.20	16.62	931.80	1009.00	-7.65
Equity	123.40	123.40	0.00	123.40	123.40	0.00	123.40	123.40	0.00
PBIDTM(%)	42.05	43.23	-2.74	42.05	43.23	-2.74	37.50	37.44	0.16

Jul, 2026

Pharma stocks trade lower as Trump proposes steep tariff on generic drugs

Lupin is currently trading at Rs. 2422.75, down by 91.65 points or 3.65% from its previous closing of Rs. 2514.40 on the BSE

Jul, 2026

Onesource Specialty Pharma submits analyst meet intimation

Onesource Specialty Pharma has informed that the Company has scheduled its Earnings Call with analysts/ investors on Saturday, July 25, 2026, at 10:00 hrs IST to discuss the unaudited financial results of the Company for the quarter ended June 30, 2026. Earnings Call details are enclosed for ready reference.

The above information is a part of company’s filings submitted to BSE.

Rank	Company	Market Capitalization 2026 (INR crores)
1	3B Blackbio Dx Ltd.	1,112 Crore
2	Aarti Drugs Ltd.	3,752 Crore
3	Aarti Pharmalabs Ltd.	6,217 Crore
4	Abbott India Ltd.	59,102 Crore
5	Acutaas Chemicals Ltd.	27,579 Crore
6	Advanced Enzyme Technologies Ltd.	3,555 Crore
7	Ajanta Pharma Ltd.	42,278 Crore
8	Akums Drugs & Pharmaceuticals Ltd.	10,638 Crore
9	Alembic Pharmaceuticals Ltd.	16,009 Crore
10	Alivus Life Sciences Ltd.	13,876 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	88.21	22.69	45.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,631	67,124	30.72	4.80	22.28	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,746	92,623	105
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	53.73
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	39.27
Aurobindo Pharma Ltd. (M)	Very Good	1,553	89,115	38.01
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	23.52
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	80.08	10.90	42.11	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	13.54
Mankind Pharma Ltd. (M)	Very Good	2,587	1,05,357	51.71	6.44	32.38	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	13.52
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	32.37
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,146	96,063	29.81	2.52	15.31	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,984	4,73,509	41.25	5.67	23.65	14.41

About MoneyWorks4Me

*Color code for outperformance consistency

*Number is average 3 year rolling returns

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Laurus Labs - Quaterly Results

Onesource Specialty - Quaterly Results

Panacea Biotec informs about disclosure

Novartis India - Quaterly Results

Pharma stocks trade lower as Trump proposes steep tariff on generic drugs

Onesource Specialty Pharma submits analyst meet intimation

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Laurus Labs - Quaterly Results

Onesource Specialty - Quaterly Results

Panacea Biotec informs about disclosure

Novartis India - Quaterly Results

Pharma stocks trade lower as Trump proposes steep tariff on generic drugs

Onesource Specialty Pharma submits analyst meet intimation

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.